Retrospective cohort of 3 million women links endometriosis subtypes to 46% higher type 2 diabetes risk

The ARCHES study analyzed health records from the Utah Population Database, identifying nearly 100,000 endometriosis cases and tracking incident type 2 diabetes diagnoses over 25 years. Researchers stratified by disease subtype and found extra-pelvic endometriosis carried the highest risk elevation, while overall association exceeded prior smaller studies that treated endometriosis as a single entity. Chronic systemic inflammation is hypothesized as a mechanistic bridge, though the observational design cannot establish temporality or rule out surveillance bias.

Notably, elevated risk appeared in premenopausal women without obesity, groups outside standard diabetes screening criteria. This pattern suggests endometriosis may accelerate metabolic dysregulation independently of adiposity-related pathways documented in general populations. Public health implications include potential earlier HbA1c monitoring for diagnosed women, yet implementation requires confirmation that screening alters long-term incidence.

Prior observational data in Diabetologia and Human Reproduction have inconsistently linked endometriosis to cardiometabolic outcomes; this large cohort resolves some heterogeneity by subtype. Future work needs prospective cohorts with biomarker panels and randomized trials of metabolic interventions in endometriosis patients to test causality and clinical utility.

Evidence quality is moderate: large sample and subtype stratification strengthen internal validity, but reliance on administrative codes and lack of adjustment for all lifestyle confounders limit causal inference. Next studies should include Mendelian randomization or interventional designs measuring diabetes incidence over five years.